View from Brussels

Peter O'Donnell is a freelance journalist who specializes in European health affairs and is based in Brussels, Belgium.

Articles

Increased public engagement leads recent change in EMA profile.

EMA: A Change in Character as Well as Powers?

The European Union has at last agreed on how HTA should be coordinated among Europe's multiple HTA agencies, bringing to an end a three-year process of discussion.

A Breakthrough or A Breakdown for Health Technology Assessment in Europe?

European authorities have announced a proposal for a framework to support not-for-profit organizations and academia in repurposing authorized medicines.

European Drug Repurposing: An Update

A new straw has appeared in the wind that may mean something more substantial will emerge than the customary rhetoric...

Is Personalized Medicine Finally Gaining Traction in Europe?

A proposal to address inequities in access to critical COVID vaccine commodities is still deadlocked a year after it was submitted.

Sharing COVID Vaccine Know-How: A New Twist on a Long-Running Debate

The EU is offering some $13 million for advice on bringing to the market medicines that combat antimicrobial resistance—and there's only one month to claim the grant...and then nine to do the work.

Multi-million European Contracts Up for Grabs for Developing Antibiotics

Pandemic sparks new advancements in clinical trial development.

Europe Seeking Clarity in Complex Clinical Trials

Slovenia brings EU health officials together for increased emphasis on repurposing.

Rhetoric and Realism Colliding on EU Discussions of Drug Repurposing

Promises of "more equitable access for those with severe diseases," "decision-making flexibility where it counts," and more in a bid to win post-Brexit business.

NICE Consults On Its New Assessment Scheme Amid A Blizzard Of Spin

European Commission proposes new bio-defense preparedness plan.